|
Jul 28
|
3 Reasons to Avoid COLL and 1 Stock to Buy Instead
|
|
Jul 25
|
Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High?
|
|
Jul 25
|
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
|
|
Jul 24
|
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
|
|
Jul 1
|
Collegium Pharmaceutical Announces Share Repurchase Program Worth $25 Million
|
|
Jun 30
|
Collegium Pharmaceutical's (NASDAQ:COLL) investors will be pleased with their favorable 71% return over the last five years
|
|
Jun 30
|
5 Insightful Analyst Questions From Collegium Pharmaceutical’s Q1 Earnings Call
|
|
Jun 4
|
1 Stock Under $50 with Exciting Potential and 2 to Turn Down
|
|
May 22
|
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)
|
|
May 20
|
Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings
|
|
May 19
|
Collegium to Participate in Upcoming Investor Conferences
|
|
Apr 28
|
3 Healthcare Stocks That Concern Us
|
|
Apr 24
|
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
|
|
Apr 23
|
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?
|
|
Feb 13
|
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
|